<SEC-DOCUMENT>9999999997-15-011260-index.html : 20150630
<SEC-HEADER>9999999997-15-011260.hdr.sgml : 20150630
<ACCEPTANCE-DATETIME>20150630090839
<PAPER>
ACCESSION NUMBER:		9999999997-15-011260
CONFORMED SUBMISSION TYPE:	ARS
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20141231
FILED AS OF DATE:		20150610
DATE AS OF CHANGE:		20150630
EFFECTIVENESS DATE:		20150610

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Celsus Therapeutics Plc.
		CENTRAL INDEX KEY:			0001541157
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				981034922
		STATE OF INCORPORATION:			X0

	FILING VALUES:
		FORM TYPE:		ARS
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36288
		FILM NUMBER:		15007784

	BUSINESS ADDRESS:	
		STREET 1:		53 DAVIES STREET
		CITY:			LONDON
		STATE:			X0
		ZIP:			W1K 5JH
		BUSINESS PHONE:		646-878-0804

	MAIL ADDRESS:	
		STREET 1:		C/O MARK COHEN, CHAIRMAN, PEARL COHEN
		STREET 2:		1500 BROADWAY, 12TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10036

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Morria Biopharmaceuticals PLC
		DATE OF NAME CHANGE:	20120201
</SEC-HEADER>
<DOCUMENT>
<TYPE>ARS
<SEQUENCE>1
<FILENAME>9999999997-15-011260.paper
<DESCRIPTION>AUTO-GENERATED PAPER DOCUMENT
<TEXT>
Document 1 - file: 9999999997-15-011260.paper

</DOCUMENT>
</SEC-DOCUMENT>